Osteosarcoma
Mepact granted Orphan Medicinal Product Designation in E.U. for osteosarcoma
Published in Women's Health Weekly, August 5th, 2004
Designation was granted following the positive opinion given by the European Medicines Agency (EMEA) and its Committee for Orphan Medicinal Products (COMP). Mepact obtained Orphan Drug Status in the United States in June 2001.
Mepact (L-MTP-PE) is an immune system stimulant designed to promote the destruction of cancer cells by activating macrophages present in the body.
A randomized phase III trial on Mepact administered after surgical resection of tumor,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
In vivo TLD dosimetry possible in mammography - Hormone Replacement Therapy
Transdermal and low-dose oral ERT does not affect homocysteine metabolism - Lipid Studies
NMR and GGE not necessarily interchangeable in women and diabetic patients - Preeclampsia
Homocysteine inversely related to folate in black women with preeclampsia - Urinary Incontinence
Study: Unnecessary to leave indwelling catheter in place for days after surgery - Abortion
Study finds women generally ambivalent about induced abortion - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
